Avitas Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $265K | Buy |
372
+42
| +13% | +$29.9K | 0.04% | 184 |
|
|
2024
Q3 | $347K | Sell |
330
-24
| -7% | -$25.2K | 0.05% | 179 |
|
|
2024
Q2 | $372K | Sell |
354
-20
| -5% | -$21K | 0.05% | 179 |
|
|
2024
Q1 | $360K | Sell |
374
-8
| -2% | -$7.7K | 0.05% | 188 |
|
|
2023
Q4 | $336K | Sell |
382
-149
| -28% | -$131K | 0.06% | 179 |
|
|
2023
Q3 | $437K | Sell |
531
-19
| -3% | -$15.6K | 0.08% | 170 |
|
|
2023
Q2 | $395K | Sell |
550
-7
| -1% | -$5.03K | 0.07% | 169 |
|
|
2023
Q1 | $458K | Sell |
557
-20
| -3% | -$16.4K | 0.09% | 160 |
|
|
2022
Q4 | $416K | Buy |
577
+2
| +0.3% | +$1.44K | 0.09% | 155 |
|
|
2022
Q3 | $396K | Buy |
575
+2
| +0.3% | +$1.38K | 0.09% | 148 |
|
|
2022
Q2 | $339K | Buy |
+573
| New | +$339K | 0.07% | 162 |
|
|
2021
Q1 | – | Sell |
-6,918
| Closed | -$3.34M | – | 225 |
|
|
2020
Q4 | $3.34M | Buy |
6,918
+334
| +5% | +$161K | 0.68% | 44 |
|
|
2020
Q3 | $3.69M | Buy |
6,584
+45
| +0.7% | +$25.2K | 1.03% | 24 |
|
|
2020
Q2 | $4.08M | Sell |
6,539
-1,092
| -14% | -$681K | 1.35% | 16 |
|
|
2020
Q1 | $3.73M | Buy |
+7,631
| New | +$3.73M | 1.7% | 12 |
|
|
2019
Q2 | – | Sell |
-7,350
| Closed | -$3.02M | – | 176 |
|
|
2019
Q1 | $3.02M | Buy |
+7,350
| New | +$3.02M | 0.88% | 45 |
|